Home › Funds › Royce & Associates › IMAX
Royce & Associates position in IMAX
IMAX CORP · Consumer Discretionary
Royce & Associates reported holding 1,251,603 shares of IMAX (IMAX CORP) in its Q3 2026 13F filing — a position valued at US$68.6M, representing 0.63% of its reported portfolio and ranking #17 among its reported holdings. Royce & Associates has disclosed IMAX holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Royce & Associates's IMAX position evolved
Royce & Associates first disclosed a stake in IMAX in Q3 2021 at 1,075,550 shares (US$20.4M). The position peaked in Q3 2026 at 1,251,603 shares, worth US$68.6M. Across 21 filings, Royce & Associates increased the stake 9 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,251,603 shares valued at US$68.6M — a reduction of -91,625 shares quarter over quarter.. Notable position changes include a 34% trim in Q1 2022 (shares fell 11% over the following quarter), a 47% increase in Q4 2022 (shares rose 31% over the following quarter), a 38% increase in Q1 2024 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.08M | $20.41M | New |
| Q4 2021 | 1.13M | $20.13M | Add |
| Q1 2022 | 746.97K | $14.14M | Reduce |
| Q2 2022 | 755.07K | $12.75M | Add |
| Q3 2022 | 755.07K | $10.66M | Hold |
| Q4 2022 | 1.11M | $16.26K | Add |
| Q1 2023 | 1.23M | $23.55K | Add |
| Q2 2023 | 1.15M | $19.51M | Reduce |
| Q3 2023 | 1.16M | $22.34M | Add |
| Q4 2023 | 1.29M | $19.32M | Add |
| Q1 2024 | 1.78M | $28.75M | Add |
| Q2 2024 | 1.77M | $29.65M | Reduce |
| Q3 2024 | 1.82M | $37.38M | Add |
| Q4 2024 | 1.77M | $45.34M | Reduce |
| Q1 2025 | 1.67M | $43.89M | Reduce |
| Q2 2025 | 1.35M | $37.76M | Reduce |
| Q3 2025 | 1.33M | $43.42M | Reduce |
| Q4 2025 | 1.26M | $46.73M | Reduce |
| Q1 2026 | 1.25M | $47.37M | Reduce |
| Q2 2026 | 1.34M | $53.54M | Add |
| Q3 2026 | 1.25M | $68.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMAX and 13F data
IMAX (IMAX CORP) is a Consumer Discretionary company. 36 other funds we track also report a position in IMAX — the largest reported positions include Orbis Allan Gray Ltd (US$162.5M), CONGRESS ASSET MANAGEMENT CO (US$139.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$128.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMAX
- Orbis Allan Gray Ltd 2.96M sh · $162.47M · Q3 2026
- CONGRESS ASSET MANAGEMENT CO 2.54M sh · $139.29M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.35M sh · $128.59M · Q3 2026
- ROYCE & ASSOCIATES LP 1.25M sh · $68.59M · Q3 2026
- EMERALD ADVISERS, LLC 834.40K sh · $45.73M · Q3 2026
- AXIOM INVESTORS LLC /DE 620.29K sh · $33.99M · Q3 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 497.25K sh · $27.25M · Q3 2026
- Pembroke Management, LTD 392.34K sh · $21.50M · Q3 2026
More on Royce & Associates
FAQ
How long has Royce & Associates held IMAX?
Royce & Associates has disclosed IMAX holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Royce & Associates's current position in IMAX?
As of Q3 2026, Royce & Associates holds 1.25M shares of IMAX (IMAX CORP), valued at $68.59M, representing 0.63% of its reported portfolio and ranking #17.
Has Royce & Associates been buying or selling IMAX?
In the latest 13F filing (Q3 2026), Royce & Associates reduced its position in IMAX. The position peaked in Q3 2026 at 1.25M shares.
Which other funds hold IMAX?
Other major institutional holders of IMAX include Orbis Allan Gray Ltd, CONGRESS ASSET MANAGEMENT CO, DRIEHAUS CAPITAL MANAGEMENT LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.